Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joseph R Merrill

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Methods in Molecular Biology (Clifton, N.J.)|November 25, 2023
CRISPR/Cas for PET Reporter Gene EngineeringTaemoon Chung, Joseph R Merrill, Scott K Lyons
Npj Imaging|July 3, 2025
The regulation of reporter transgene expression for diverse biological imaging applicationsAlexandria S Battison, Joseph R Merrill, Jeremy C Borniger, et al.
Cold Spring Harbor Perspectives in Medicine|March 19, 2024
Addressing Biological Questions with Preclinical Cancer ImagingChris B Damoci, Joseph R Merrill, Yanping Sun, et al.
Current Radiopharmaceuticals|August 27, 2016
Automated PET Radiotracer Manufacture on the BG75 System and Imaging Validation Studies of [18F]fluoromisonidazole ([18F]FMISO)Hong Yuan, Jonathan E Frank, Joseph R Merrill, et al.
Data in Brief|March 26, 2016
Data on biodistribution and radiation absorbed dose profile of a novel (64)Cu-labeled high affinity cell-specific peptide for positron emission tomography imaging of tumor vasculatureJoseph R Merrill, Krzysztof Krajewski, Hong Yuan, et al.
Biomaterials|February 4, 2016
Synthesis and comparative evaluation of novel (64)Cu-labeled high affinity cell-specific peptides for positron emission tomography imaging of tumor vasculatureJoseph R Merrill, Krzysztof Krajewski, Hong Yuan, et al.
Cell Stress|September 4, 2023
Sensitive, non-immunogenic <i>in vivo</i> imaging of cancer metastases and immunotherapy responseJoseph R Merrill, Alessandra Inguscio, Taemoon Chung, et al.
Scientific Reports|December 13, 2017
The Toll-Like Receptor 2/6 Agonist, FSL-1 Lipopeptide, Therapeutically Mitigates Acute Radiation SyndromeCathryn J Kurkjian, Hao Guo, Nathan D Montgomery, et al.
Diagnostics (Basel, Switzerland)|April 30, 2021
Assessment of <sup>18</sup>F-PBR-111 in the Cuprizone Mouse Model of Multiple SclerosisValerie L Jewells, Hong Yuan, Joseph R Merrill, et al.
Clinical Immunology (Orlando, Fla.)|August 28, 2018
IL-11 antagonist suppresses Th17 cell-mediated neuroinflammation and demyelination in a mouse model of relapsing-remitting multiple sclerosisXin Zhang, Nazanin Kiapour, Sahil Kapoor, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Methods in Molecular Biology (Clifton, N.J.)|November 25, 2023
CRISPR/Cas for PET Reporter Gene EngineeringTaemoon Chung, Joseph R Merrill, Scott K Lyons
Npj Imaging|July 3, 2025
The regulation of reporter transgene expression for diverse biological imaging applicationsAlexandria S Battison, Joseph R Merrill, Jeremy C Borniger, et al.
Cold Spring Harbor Perspectives in Medicine|March 19, 2024
Addressing Biological Questions with Preclinical Cancer ImagingChris B Damoci, Joseph R Merrill, Yanping Sun, et al.
Current Radiopharmaceuticals|August 27, 2016
Automated PET Radiotracer Manufacture on the BG75 System and Imaging Validation Studies of [18F]fluoromisonidazole ([18F]FMISO)Hong Yuan, Jonathan E Frank, Joseph R Merrill, et al.
Data in Brief|March 26, 2016
Data on biodistribution and radiation absorbed dose profile of a novel (64)Cu-labeled high affinity cell-specific peptide for positron emission tomography imaging of tumor vasculatureJoseph R Merrill, Krzysztof Krajewski, Hong Yuan, et al.
Biomaterials|February 4, 2016
Synthesis and comparative evaluation of novel (64)Cu-labeled high affinity cell-specific peptides for positron emission tomography imaging of tumor vasculatureJoseph R Merrill, Krzysztof Krajewski, Hong Yuan, et al.
Cell Stress|September 4, 2023
Sensitive, non-immunogenic <i>in vivo</i> imaging of cancer metastases and immunotherapy responseJoseph R Merrill, Alessandra Inguscio, Taemoon Chung, et al.
Scientific Reports|December 13, 2017
The Toll-Like Receptor 2/6 Agonist, FSL-1 Lipopeptide, Therapeutically Mitigates Acute Radiation SyndromeCathryn J Kurkjian, Hao Guo, Nathan D Montgomery, et al.
Diagnostics (Basel, Switzerland)|April 30, 2021
Assessment of <sup>18</sup>F-PBR-111 in the Cuprizone Mouse Model of Multiple SclerosisValerie L Jewells, Hong Yuan, Joseph R Merrill, et al.
Clinical Immunology (Orlando, Fla.)|August 28, 2018
IL-11 antagonist suppresses Th17 cell-mediated neuroinflammation and demyelination in a mouse model of relapsing-remitting multiple sclerosisXin Zhang, Nazanin Kiapour, Sahil Kapoor, et al.
Pageof 2